What Could This Mean for Your CGM
Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota
Emerging research suggests that by improving metabolic health and promoting significant weight loss, Semaglutide may help lower the risk of certain obesity-related cancers, including colorectal and breast cancer
The most common side effects of Wegovy include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with diabetes, flatulence (gas buildup) and gastroesophageal reflux disease (heartburn)
Wang X, Zhu Y, Wang S, Wang Z, Sun H, He Y, et al